US Patent Issued to Novartis on May 12 for "Trispecific binding molecules against BCMA and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,118, issued on May 12, was assigned to Novartis AG (Basel, Switzerland).

"Trispecific binding molecules against BCMA and uses thereof" was invented by Brian Walter Granda (Salisbury, Mass.), John Blankenship (Acton, Mass.), Aida Abujoub (Winchester, Mass.), Tony Fleming (Stow, Mass.), Lu Huang (West Roxbury, Mass.), Connie Hong (Somerville, Mass.), Brian Holmberg (Somerville, Mass.) and Haihui Lu (Winchester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides multispecific binding molecules that specifically bind to BCMA, a component of a human T-cell receptor complex and either CD2 or a tumor associated antigen, con...